Prescient Therapeutics LimitedASX: PTX

PTX-200 Phase 1b Breast Cancer Trial Results

Apr 10, 2018 at 3:48 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment